186 related articles for article (PubMed ID: 34242618)
1. Dysregulated ECM remodeling proteins lead to aberrant osteogenesis of Costello syndrome iPSCs.
Choi JB; Lee J; Kang M; Kim B; Ju Y; Do HS; Yoo HW; Lee BH; Han YM
Stem Cell Reports; 2021 Aug; 16(8):1985-1998. PubMed ID: 34242618
[TBL] [Abstract][Full Text] [Related]
2. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
3. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
5. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin.
Balogh E; Tolnai E; Nagy B; Nagy B; Balla G; Balla J; Jeney V
Biochim Biophys Acta; 2016 Sep; 1862(9):1640-9. PubMed ID: 27287253
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 inhibits proliferation and osteogenic differentiation of hBMSCs through Wnt/β-catenin signaling.
Liang T; Gao W; Zhu L; Ren J; Yao H; Wang K; Shi D
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30473539
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-218 competes with differentiation media in the induction of osteogenic differentiation of mesenchymal stem cell by regulating β-catenin inhibitors.
Karimi Z; Seyedjafari E; Khojasteh A; Hashemi SM; Kazemi B; Mohammadi-Yeganeh S
Mol Biol Rep; 2020 Nov; 47(11):8451-8463. PubMed ID: 33051753
[TBL] [Abstract][Full Text] [Related]
9. Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient.
Choi JY; Han KM; Kim D; Lee BH; Yoo HW; Choi JH; Han YM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194391
[TBL] [Abstract][Full Text] [Related]
10. miR‑29b promotes the osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue via the PTEN/AKT/β‑catenin signaling pathway.
Xia T; Dong S; Tian J
Int J Mol Med; 2020 Aug; 46(2):709-717. PubMed ID: 32468003
[TBL] [Abstract][Full Text] [Related]
11. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of mouse-induced pluripotent stem cells and mesenchymal stem cells during osteogenic differentiation in vitro.
Egusa H; Kayashima H; Miura J; Uraguchi S; Wang F; Okawa H; Sasaki J; Saeki M; Matsumoto T; Yatani H
Stem Cells Dev; 2014 Sep; 23(18):2156-69. PubMed ID: 24625139
[TBL] [Abstract][Full Text] [Related]
13. Tricin enhances osteoblastogenesis through the regulation of Wnt/β-catenin signaling in human mesenchymal stem cells.
Zhang H; Li H
Mech Dev; 2018 Aug; 152():38-43. PubMed ID: 30056839
[TBL] [Abstract][Full Text] [Related]
14. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
[TBL] [Abstract][Full Text] [Related]
15. Effect of TAK1 on osteogenic differentiation of mesenchymal stem cells by regulating BMP-2 via Wnt/β-catenin and MAPK pathway.
Yang H; Guo Y; Wang D; Yang X; Ha C
Organogenesis; 2018 Jan; 14(1):36-45. PubMed ID: 29913119
[TBL] [Abstract][Full Text] [Related]
16. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering.
Liu J; Chen W; Zhao Z; Xu HH
Biomaterials; 2013 Oct; 34(32):7862-72. PubMed ID: 23891395
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells.
Wang P; Ma T; Guo D; Hu K; Shu Y; Xu HHK; Schneider A
J Tissue Eng Regen Med; 2018 Feb; 12(2):437-446. PubMed ID: 28494141
[TBL] [Abstract][Full Text] [Related]
19. Promotion of osteogenesis through beta-catenin signaling by desferrioxamine.
Qu ZH; Zhang XL; Tang TT; Dai KR
Biochem Biophys Res Commun; 2008 May; 370(2):332-7. PubMed ID: 18375202
[TBL] [Abstract][Full Text] [Related]
20. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
